Compatibility and Safety Implications Associated with Interfacing Medical Devices in Neonatal Respiratory Care: A Case Example Using the Inhaled Nitric Oxide Delivery System
Anthony L DeWitt,1 Jaron Acker,2 Thomas A Larkin,3 Jim L Potenziano,4 Jeffrey M Schmidt5 1Penumbra Seminars, LLC, Auburn, AL, USA; 2Medical Device Marketing, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA; 3Device Engineering R&D, Mallinckrodt Pharmaceuticals Ireland Ltd., Dublin, Ireland...
Guardado en:
Autores principales: | DeWitt AL, Acker J, Larkin TA, Potenziano JL, Schmidt JM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0baad3c5310d4d9ca8ebb648def53b16 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rationale for Use of an FDA-Cleared Delivery System for Administration of Inhaled Nitric Oxide in Patients Undergoing Magnetic Resonance Imaging
por: Salas M, et al.
Publicado: (2021) -
Inhalation drug delivery devices: technology update
por: Ibrahim M, et al.
Publicado: (2015) -
Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders
por: Dalby RN, et al.
Publicado: (2011) -
Fractional exhaled nitric oxide-measuring devices: technology update
por: Maniscalco M, et al.
Publicado: (2016) -
Disruption in the diabetic device care market
por: Ojha U, et al.
Publicado: (2018)